Astera Labs Earnings Calls
| Release date | May 05, 2026 |
| EPS estimate | $0.537 |
| EPS actual | $0.610 |
| EPS Surprise | 13.59% |
| Revenue estimate | 292.194M |
| Revenue actual | 308.361M |
| Revenue Surprise | 5.53% |
| Release date | Feb 10, 2026 |
| EPS estimate | $0.516 |
| EPS actual | $0.580 |
| EPS Surprise | 12.40% |
| Revenue estimate | 249.545M |
| Revenue actual | 270.583M |
| Revenue Surprise | 8.43% |
| Release date | Nov 04, 2025 |
| EPS estimate | $0.390 |
| EPS actual | $0.490 |
| EPS Surprise | 25.67% |
| Revenue estimate | 206.459M |
| Revenue actual | 230.575M |
| Revenue Surprise | 11.68% |
| Release date | Aug 05, 2025 |
| EPS estimate | $0.324 |
| EPS actual | $0.440 |
| EPS Surprise | 35.76% |
| Revenue estimate | 172.492M |
| Revenue actual | 191.925M |
| Revenue Surprise | 11.27% |
Last 4 Quarters for Astera Labs
Below you can see how ALAB performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 05, 2025 |
| Price on release | $135.54 |
| EPS estimate | $0.324 |
| EPS actual | $0.440 |
| EPS surprise | 35.76% |
| Date | Price |
|---|---|
| Jul 30, 2025 | $128.87 |
| Jul 31, 2025 | $136.73 |
| Aug 01, 2025 | $131.10 |
| Aug 04, 2025 | $137.93 |
| Aug 05, 2025 | $135.54 |
| Aug 06, 2025 | $174.39 |
| Aug 07, 2025 | $170.89 |
| Aug 08, 2025 | $179.28 |
| Aug 11, 2025 | $179.43 |
| 4 days before | 5.18% |
| 4 days after | 32.38% |
| On release day | 28.66% |
| Change in period | 39.23% |
| Release date | Nov 04, 2025 |
| Price on release | $179.31 |
| EPS estimate | $0.390 |
| EPS actual | $0.490 |
| EPS surprise | 25.67% |
| Date | Price |
|---|---|
| Oct 29, 2025 | $173.62 |
| Oct 30, 2025 | $169.55 |
| Oct 31, 2025 | $186.68 |
| Nov 03, 2025 | $191.56 |
| Nov 04, 2025 | $179.31 |
| Nov 05, 2025 | $181.94 |
| Nov 06, 2025 | $162.83 |
| Nov 07, 2025 | $165.49 |
| Nov 10, 2025 | $173.74 |
| 4 days before | 3.28% |
| 4 days after | -3.11% |
| On release day | 1.47% |
| Change in period | 0.0691% |
| Release date | Feb 10, 2026 |
| Price on release | $182.86 |
| EPS estimate | $0.516 |
| EPS actual | $0.580 |
| EPS surprise | 12.40% |
| Date | Price |
|---|---|
| Feb 04, 2026 | $144.67 |
| Feb 05, 2026 | $142.82 |
| Feb 06, 2026 | $169.85 |
| Feb 09, 2026 | $187.67 |
| Feb 10, 2026 | $182.86 |
| Feb 11, 2026 | $143.71 |
| Feb 12, 2026 | $126.58 |
| Feb 13, 2026 | $129.32 |
| Feb 17, 2026 | $123.69 |
| 4 days before | 26.40% |
| 4 days after | -32.36% |
| On release day | -21.41% |
| Change in period | -14.50% |
| Release date | May 05, 2026 |
| Price on release | $215.69 |
| EPS estimate | $0.537 |
| EPS actual | $0.610 |
| EPS surprise | 13.59% |
| Date | Price |
|---|---|
| Apr 29, 2026 | $196.85 |
| Apr 30, 2026 | $194.74 |
| May 01, 2026 | $202.68 |
| May 04, 2026 | $201.25 |
| May 05, 2026 | $215.69 |
| May 06, 2026 | $213.91 |
| May 07, 2026 | $195.65 |
| May 08, 2026 | $199.79 |
| May 11, 2026 | $207.35 |
| 4 days before | 9.57% |
| 4 days after | -3.87% |
| On release day | -0.83% |
| Change in period | 5.33% |
Astera Labs Earnings Call Transcript Summary of Q1 2026
Astera Labs reported a strong Q1 FY2026 with revenue of $308.4M, up 14% sequentially and 93% year-over-year, and non-GAAP EPS of $0.61. Growth was broad-based across signal conditioning (Aries, Taurus) and the Scorpio fabric switch family, with PCIe Gen6 products contributing over one-third of revenue. The company is ramping initial volume shipments of Scorpio X-Series (including a newly introduced 320-lane high-radix model) with full production expected in H2 2026, and expects Scorpio to become its largest product line by year-end. Astera is expanding its optical roadmap after acquiring aiXscale Photonics, targeting NPO and CPO deployments and volume connector shipments beginning in 2027. The Leo CXL controller is tracking for early ramp with Microsoft Azure M-Series and the company secured a custom KV Cache design expected to ship in 2027. Financially, Q1 non-GAAP gross margin was 76.4%; operating expenses reflect continued R&D investments (including aiXscale integration and a new Israel design center). Cash and equivalents were $1.18B. Q2 guidance: revenue $355M–$365M (up 15%-18% sequentially), non-GAAP EPS $0.68–$0.70, non-GAAP gross margin ~73% (including a ~200bp noncash warrant impact), and operating expenses $128M–$131M. Management emphasized secular tailwinds from accelerated AI infrastructure spending, expansion into higher-value and custom solutions (NVLink Fusion, KV Cache, UALink), and continued strategic investments to drive growth above market rates.
Sign In
Buy ALAB